Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation

Clinical Transplantation

Volumn 20, Issue SUPPL. 15, 2006, Pages 26-32

  Harada, Hiroshi ^a   Miura, Masayoshi ^a   Ogawa, Yayoi ^a   Seki, Toshimori ^a   Taniguchi, Akihisa ^a   Takenouchi, Toshinao ^a   Togashi, Masaki ^a   Hirano, Tetsuo ^a  

^a SAPPORO CITY GENERAL HOSPITAL   (Japan)

Author keywords

Kidney transplantation; Late corticosteroid withdrawal; Pathological confirmation

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DRUG DOSE REGIMEN; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; METABOLIC PARAMETERS; PATIENT SAFETY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADRENAL CORTEX HORMONES; ADULT; ANTIMETABOLITES; BIOPSY; CALCINEURIN; DRUG THERAPY, COMBINATION; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33746430034     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00546.x     Document Type: Article

References (19)

1. Rama I, Cruzado JM, Gil-Vernet S et al. Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: Long-term results. Transplantation 2005: 80: 164.
2. Pascual J, Quereda C, Zamora J, Hernandez D. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: A meta-analysis of randomized, controlled trials. Transplantation 2004: 78: 1548.
3. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
4. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003: 3: 708.
5. Chobanian AV, Bakris GL, Black HR et al. The National High Blood Pressure Education Program Coordination Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003: 289: 2560.
6. Kuzuya T, Nakagawa S, Satoh J et al. Report of the committee of Japan Diabetes Society of the Classification and Diagnostic Criteria of Diabetes Mellitus. J Japan Diab Soc 1999: 42: 385.
7. Japan Atherosclerosis Society. Chapter 2. In: Teramoto T, ed. Japan Atherosclerosis Society (JAS) Guidelines for Diagnosis and Treatment of Atherosclerotic Caridiovascular Diseases. Tokyo: Japan Atherosclerosis Society, 2002: 5 (in Japanese).
8. C antarovich D, K aram G, H ourmant M et al. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation. Am J Transplant 2005: 5: 1332.
9. Klaus G, Jeck N, Konrad M, Forster B, Soergel M. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity. Clin Nephrol 2001: 56: S37.
10. Wlodarczyk Z, Walaszewski J, Perner F et al. Steroid withdrawal at 3 months after kidney transplantation: A comparison of two tacrolimus-based regimens. Transpl Int 2005: 18: 157.
11. Matl I, Lacha J, Lodererova A et al. Withdrawal of steroids from triple-drug therapy in kidney transplant patients. Nephrol Dial Transplant 2000: 15: 1041.
12. Opelz G, Dohler B, Laux G. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005: 5: 720.
13. Ando T, Tojimbara T, Sato S et al. Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: A rapid steroid withdrawal protocol. Transplant Proc 2004: 36: 2182.
14. Rogers CC, Alloway RR, Buell JF et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation 2005: 80: 26.
15. Laftavi MR, Stephan R, Stefanick B et al. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery 2005: 137: 364.
16. Ratcliffe PJ, Dudley CR, Higgins RM, Firth JD, Smith B, Morris PJ. Randomized controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996: 348: 643.
17. Sanfey H, Haussman G, Isaacs I et al. Steroid withdrawal in kidney transplant recipients: Is it a safe option? Clin Transplant 1997: 11: 500.
18. Sone H, Mizuno S, Fujii H et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Diabetes Care 2005: 28: 1463.
19. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999: 33: 829.